Intra-Cellular Therapies Newsroom

Intra-Cellular Therapies Presents Data From The CAPLYTA Adjunctive MDD Phase 3 Program At The American College Of Neuropsychopharmacology Annual Meeting; Data Shows Robust Remission And Response Efficacy Rates In Patients Taking CAPLYTA, As Well As...

BenzingaDec 11 08:08 ET

Insider Sale: Chairman and CEO of $ITCI (ITCI) Sells 1,534 Shares

Quiver QuantitativeDec 6 18:16 ET

Intra-Cellular Therapies(ITCI.US) Officer Sells US$8.72 Million in Common Stock

Moomoo NewsDec 6 18:06 ET

Express News | Form 144 | Intra-Cellular Therapies(ITCI.US) Officer Proposes to Sell 4.34 Million in Common Stocks

Moomoo NewsDec 5 16:30 ET

Express News | Form 144 | Intra-Cellular Therapies(ITCI.US) Officer Proposes to Sell 4.37 Million in Common Stocks

Moomoo NewsDec 4 16:23 ET

We're Interested To See How Intra-Cellular Therapies (NASDAQ:ITCI) Uses Its Cash Hoard To Grow

Simply Wall StDec 3 13:53 ET

Intra-Cellular Therapies Files Supplemental NDA for Caplyta as Adjunctive Treatment for Major Depressive Disorder

MT NewswiresDec 3 10:59 ET

Express News | Intra-Cellular Therapies Submits Supplemental New Drug Application (Snda) to FDA for Caplyta® (Lumateperone) for the Treatment of Major Depressive Disorder as Adjunctive Therapy

ReutersDec 3 07:30 ET

Jefferies Maintains Intra-Cellular Therapies(ITCI.US) With Buy Rating, Maintains Target Price $105

Moomoo NewsDec 2 08:32 ET · Ratings

Mizuho Securities Maintains Intra-Cellular Therapies(ITCI.US) With Buy Rating, Announces Target Price $100

Moomoo NewsNov 29 12:32 ET · Ratings

RBC Capital Sticks to Their Buy Rating for Intra-Cellular Therapies (ITCI)

TipRanksNov 27 20:47 ET · Ratings

Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM

Seeking AlphaNov 26 14:01 ET

UBS Maintains Intra-Cellular Therapies(ITCI.US) With Hold Rating, Raises Target Price to $87

Moomoo NewsNov 19 13:31 ET · Ratings

Express News | Intra-Cellular Therapies Inc : UBS Raises Target Price to $87 From $79

ReutersNov 19 10:39 ET

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

GlobeNewswireNov 19 08:00 ET

US Manufacturing Index Rises To 43, Highest Since 2020

Business TodayNov 16 02:13 ET

Intra-Cellular Therapies(ITCI.US) Officer Sells US$3.69 Million in Common Stock

Moomoo NewsNov 14 18:08 ET

Form 144 | Intra-Cellular Therapies(ITCI.US) Officer Proposes to Sell 3.7 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Nov 12, $Intra-Cellular Therapies(ITCI.US)$ Officer Halstead Michael intends to sell 41,583 shares of its common stock on Nov 12, with a total market value of approximately $3.

Moomoo NewsNov 12 16:34 ET

Intra-Cellular Therapies, Inc.'s (NASDAQ:ITCI) P/S Is Still On The Mark Following 26% Share Price Bounce

Simply Wall StNov 7 06:47 ET

Intra-Cellular Therapies' Treatment Reduces Schizophrenia Relapse Risk 63%

BenzingaNov 5 12:10 ET